Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
2
Mins
26th November 2019
Autoimmune Bullous Skin Disorder Induced by PD-1 Inhibitors
Immune checkpoint inhibitors are important therapeutic modalities not only against metastatic melanoma, but in other malignant disorders, including…
1
Mins
26th November 2019
Analysis of Methods of the Demodex Mites Diagnosis
Demodex mites are microscopic arthropods that present in the pilosebaceous units of the human skin.1,2 Demodex mites support the severity of the inflammatory process in dermatoses such as acne, rosacea, seborrheic…
11
Mins
26th November 2019
IL-23 Inhibitors for Moderate-to-Severe Plaque Psoriasis: A Review of Clinical Efficacy, Safety, and Tolerability
Psoriasis is a common, chronic, immune-mediated skin disease affecting approximately 2–3% of the global population…
2
Mins
26th November 2019
Apulian Experience with the Innovative Drug for Atopic Dermatitis: Dupilumab
Four patients with long-standing atopic dermatitis (AD) with elevated Eczema Area and Severity Index (EASI) and nonresponders to common therapies…
1
Mins
26th November 2019
Cutaneous Adverse Effects Induced by Nivolumab
Nivolumab is a humanised IgG4 monoclonal antibody that binds the programmed cell death protein 1 (PD-1) receptor and blocks interaction with its ligand…
2
Mins
26th November 2019
Erythema Multiforme: A Clinical Study of Thirty-Two Patients
Erythema multiforme (EM) is an acute, immune-mediated skin condition that infection or medication can trigger. It occurs most frequently in young adults…
1
Mins
26th November 2019
Combined Treatment of Acneiform Rash Involved in Epidermal Growth Factor Receptor Inhibitors Therapy
Acneiform rash has a great influence on patient quality of life. Such severe dermatologic reactions are induced by epidermal growth factor receptor…
25th November 2019
ESC 2019 – Interview – Dr Donald Lloyd-Jones
An interview with Dr Donald Lloyd-Jones, Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Illinois, USA.
5
Mins
22nd November 2019
Edge-to-Edge Repair After Prior Left-Sided Pneumonectomy
Cardiac procedures and operations following pneumonectomy present with serious challenges, both surgical and anaesthetic…
6
Mins
21st November 2019
The Potential of Biomedical Engineering in Respiratory Health
During this year’s European Society of Respiratory (ERS) International Congress, we spoke to Prof Geoffrey Maksym, Director, Professor, School…
←
1
2
3
…
533
534
535
536
537
538
539
…
911
912
913
→